Johnson & Johnson agreeing to pay $25 million after its subsidiary, McNeil, failed to initiate or complete the FDA’s corrective action plan for manufacturing issues that led to particles in bottles of children’s Tylenol is yet another reminder that the medicines we purchase for ourselves and our children are not always safe.
The public and the FDA have lost faith in how the company manages quality-control issues - so the Fort Washington, PA plant in question remains offline pending completion of FDA inspections. Read the full story here.
PartnerWilliam T. Gibbs is a partner at the Chicago personal injury and medical malpractice law firm of Corboy & Demetrio and concentrates his practice on cases arising from railroad negligence, automobile collisions, participation in ...